doi: 10.1007/BF00188804.
The genetic effect of engineered vaccine on Pseudomonas aeruginosa infection in mice
Affiliations
- PMID: 8319977
- DOI: 10.1007/BF00188804
Item in Clipboard
The genetic effect of engineered vaccine on Pseudomonas aeruginosa infection in mice
Immunogenetics.
1993.
No abstract available
Similar articles
-
Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.Biomed Pept Proteins Nucleic Acids. 1995;1(3):141-8. Biomed Pept Proteins Nucleic Acids. 1995. PMID: 9346845
-
Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.Microb Pathog. 2019 Jun;131:181-185. doi: 10.1016/j.micpath.2019.04.014. Epub 2019 Apr 9. Microb Pathog. 2019. PMID: 30978430
-
Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.Bioengineered. 2015;6(2):82-8. doi: 10.1080/21655979.2015.1011033. Bioengineered. 2015. PMID: 25617059 Free PMC article.
-
Conjugate vaccines against Pseudomonas aeruginosa and malaria.Contrib Microbiol Immunol. 1989;10:166-89. Contrib Microbiol Immunol. 1989. PMID: 2510972 Review. No abstract available.
-
Current status of Pseudomonas aeruginosa vaccine.Curr Pharm Biotechnol. 2013;14(11):951-9. doi: 10.2174/1389201014666131226143923. Curr Pharm Biotechnol. 2013. PMID: 24372247 Review.
Cited by
-
Pseudomonas aeruginosa phage lysate as an immunobiological agent. 1. Selection of Pseudomonas aeruginosa clinical strains for phage lysate preparation.Folia Microbiol (Praha). 1999;44(1):93-7. doi: 10.1007/BF02816229. Folia Microbiol (Praha). 1999. PMID: 10489698